Literature DB >> 23179521

Hepatocellular carcinoma in cirrhotic patients: prospective comparison of US, CT and MR imaging.

Michele Di Martino1, Gianmaria De Filippis, Adriano De Santis, Daniel Geiger, Maurizio Del Monte, Concetta Valentina Lombardo, Massimo Rossi, Stefano Ginanni Corradini, Gianluca Mennini, Carlo Catalano.   

Abstract

OBJECTIVES: To prospectively compare the diagnostic performance of ultrasound (US), multidetector computed tomography (MDCT) and contrast-enhanced magnetic resonance imaging (MRI) in cirrhotic patients who were candidates for liver transplantation.
METHODS: One hundred and forty consecutive patients with 163 hepatocellular carcinoma (HCC) nodules underwent US, MRI and MDCT. Diagnosis of HCC was based on pathological findings or substantial growth at 12-month follow-up. Four different image datasets were evaluated: US, MDCT, MRI unenhanced and dynamic phases, MRI unenhanced dynamic and hepatobiliary phase. Diagnostic accuracy, sensitivity, specificity, PPV and NPV, with corresponding 95 % confidence intervals, were determined. Statistical analysis was performed for all lesions and for three lesion subgroups (<1 cm, 1-2 cm, >2 cm).
RESULTS: Significantly higher diagnostic accuracy, sensitivity and NPV was achieved on dynamic + hepatobiliary phase MRI compared with US, MDCT and dynamic phase MRI alone. The specificity and PPV of US was significantly lower than that of MDCT, dynamic phase MRI and dynamic + hepatobiliary phase MRI. Similar results were obtained for all sub-group analyses, with particular benefit for the diagnosis of smaller lesions between 1 and 2 cm.
CONCLUSIONS: Dynamic + hepatobiliary phase MRI improved detection and characterisation of HCC in cirrhotic patients. The greatest benefit is for diagnosing lesions between 1 and 2 cm.

Entities:  

Mesh:

Year:  2012        PMID: 23179521     DOI: 10.1007/s00330-012-2691-z

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  35 in total

Review 1.  Hepatocellular nodules in liver cirrhosis: contrast-enhanced MR.

Authors:  Carlo Bartolozzi; Valentina Battaglia; Elena Bozzi
Journal:  Abdom Imaging       Date:  2011-06

2.  Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.

Authors:  Peng-Ju Xu; Fu-Hua Yan; Jian-Hua Wang; Yan Shan; Yuan Ji; Cai-Zhong Chen
Journal:  J Comput Assist Tomogr       Date:  2010-07       Impact factor: 1.826

Review 3.  Ultrasound of focal liver lesions.

Authors:  C J Harvey; T Albrecht
Journal:  Eur Radiol       Date:  2001       Impact factor: 5.315

Review 4.  Epidemiology and management of hepatocellular carcinoma.

Authors:  Ju Dong Yang; Lewis R Roberts
Journal:  Infect Dis Clin North Am       Date:  2010-12       Impact factor: 5.982

5.  Contrast-enhanced sonography for the characterisation of hepatocellular carcinomas--correlation with histological differentiation.

Authors:  D Strobel; C Kleinecke; J Hänsler; M Frieser; T Händl; E G Hahn; T Bernatik
Journal:  Ultraschall Med       Date:  2005-08       Impact factor: 6.548

6.  Comparison of superparamagnetic iron oxide-enhanced and gadobenate dimeglumine-enhanced dynamic MRI for detection of small hepatocellular carcinomas.

Authors:  Young Kon Kim; Chong Soo Kim; Young Hwan Lee; Hyo Sung Kwak; Jeong Min Lee
Journal:  AJR Am J Roentgenol       Date:  2004-05       Impact factor: 3.959

7.  Characterization of focal hepatic lesions with duplex sonography: findings in 198 patients.

Authors:  C Reinhold; L Hammers; C R Taylor; C L Quedens-Case; C K Holland; K J Taylor
Journal:  AJR Am J Roentgenol       Date:  1995-05       Impact factor: 3.959

8.  Detection of hepatocellular carcinoma in patients with cirrhosis: added value of coronal reformations from isotropic voxels with 64-MDCT.

Authors:  Daniele Marin; Carlo Catalano; Gianmaria De Filippis; Michele Di Martino; Antonino Guerrisi; Massimo Rossi; Roberto Passariello
Journal:  AJR Am J Roentgenol       Date:  2009-01       Impact factor: 3.959

9.  Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma.

Authors:  Alejandro Forner; Ramón Vilana; Carmen Ayuso; Lluís Bianchi; Manel Solé; Juan Ramón Ayuso; Loreto Boix; Margarita Sala; María Varela; Josep M Llovet; Concepció Brú; Jordi Bruix
Journal:  Hepatology       Date:  2008-01       Impact factor: 17.425

10.  Management of hepatocellular carcinoma: an update.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2011-03       Impact factor: 17.425

View more
  26 in total

1.  Perfusion computed tomography for detection of hepatocellular carcinoma in patients with liver cirrhosis.

Authors:  Michael A Fischer; Nikolaos Kartalis; Aristeidis Grigoriadis; Louiza Loizou; Per Stål; Bertil Leidner; Peter Aspelin; Torkel B Brismar
Journal:  Eur Radiol       Date:  2015-04-23       Impact factor: 5.315

Review 2.  Contrast-enhanced ultrasound in liver cancer.

Authors:  Simona Leoni; Ilaria Serio; Anna Pecorelli; Sara Marinelli; Luigi Bolondi
Journal:  Hepat Oncol       Date:  2015-01-12

3.  Neural network ensemble based CAD system for focal liver lesions from B-mode ultrasound.

Authors:  Jitendra Virmani; Vinod Kumar; Naveen Kalra; Niranjan Khandelwal
Journal:  J Digit Imaging       Date:  2014-08       Impact factor: 4.056

Review 4.  Hepatocellular carcinoma: can circulating tumor cells and radiogenomics deliver personalized care?

Authors:  Richard L Hesketh; Andrew X Zhu; Rahmi Oklu
Journal:  Am J Clin Oncol       Date:  2015-08       Impact factor: 2.339

Review 5.  Radiomics and circulating tumor cells: personalized care in hepatocellular carcinoma?

Authors:  Richard L Hesketh; Andrew X Zhu; Rahmi Oklu
Journal:  Diagn Interv Radiol       Date:  2015 Jan-Feb       Impact factor: 2.630

Review 6.  Abbreviated MRI for Hepatocellular Carcinoma Screening and Surveillance.

Authors:  Julie Y An; Miguel A Peña; Guilherme M Cunha; Michael T Booker; Bachir Taouli; Takeshi Yokoo; Claude B Sirlin; Kathryn J Fowler
Journal:  Radiographics       Date:  2020 Nov-Dec       Impact factor: 5.333

Review 7.  Tumor Markers for Hepatocellular Carcinoma: Simple and Significant Predictors of Outcome in Patients with HCC.

Authors:  Hidenori Toyoda; Takashi Kumada; Toshifumi Tada; Yasuhiro Sone; Yuji Kaneoka; Atsuyuki Maeda
Journal:  Liver Cancer       Date:  2015-03       Impact factor: 11.740

8.  [Oncologic imaging: indications for and limitations of modern cross-sectional imaging techniques].

Authors:  M E Mayerhoefer; A Ba-Ssalamah; H Prosch
Journal:  Radiologe       Date:  2013-04       Impact factor: 0.635

9.  Hepatocellular carcinoma detection in liver cirrhosis: diagnostic performance of contrast-enhanced CT vs. MRI with extracellular contrast vs. gadoxetic acid.

Authors:  Sahar Semaan; Naik Vietti Violi; Sara Lewis; Manjil Chatterji; Christopher Song; Cecilia Besa; James S Babb; M Isabel Fiel; Myron Schwartz; Swan Thung; Claude B Sirlin; Bachir Taouli
Journal:  Eur Radiol       Date:  2019-10-31       Impact factor: 5.315

Review 10.  Surveillance for hepatocellular carcinoma in chronic liver disease: evidence and controversies.

Authors:  Suzanne van Meer; Robert A de Man; Peter D Siersema; Karel J van Erpecum
Journal:  World J Gastroenterol       Date:  2013-10-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.